Award

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline

Description: PROJECT NARRATIVE Accelerated decline in physical function is a common adverse health effect of breast cancer chemotherapy linked to premature frailty, disability, and death. We hypothesize that targeting senescent cells, using exercise and treatments that ablate senescent cells, will improve chemotherapy-induced functional decline. If our hypothesis is correct, the impact on clinical practice would be substantial and will extend far beyond oncology.
Funding type: research
Funder scheme: R01
Start date: 2023-09-01
End date: 2028-08-31
Investigator: MINA S SEDRAK (lead)
Institutions: University of California, Los Angeles, UNIVERSITY OF CALIFORNIA LOS ANGELES
Subfield: Cell Biology
Funded outputs count: 13
Funder award ID: R01CA280088
OpenAlex ID: G9000874987
2026 · Jingran Ji, Harvey Jay Cohen, et al. · JNCI Journal of the National Cancer Institute
2026 · Samuel Margolis, Andre Naguib Guirguis, et al. · Breast Cancer Research and Treatment
2026 · Jingran Ji, Can-Lan Sun, et al. · JNCI Journal of the National Cancer Institute · 2
2026 · Jingran Ji, Mina S Sedrak · The Journals of Gerontology Series A
2026 · José Pablo Leone, Mina S. Sedrak · Clinical Breast Cancer
2024 · Jeanne S Mandelblatt, Michael H Antoni, et al. · JNCI Journal of the National Cancer Institute · 29